# Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct

> **NCT05709509** · PHASE4 · UNKNOWN · sponsor: **RSD dr. Soebandi** · enrollment: 148 (estimated)

## Conditions studied

- ST Elevation Myocardial Infarction
- Colchicine
- Cardiac Remodeling, Ventricular

## Interventions

- **DRUG:** Colchicine
- **PROCEDURE:** Percutaneous Coronary Intervention
- **OTHER:** Optimal medical treatment including statin, aspirin, P2Y12 inhibitor, and nitrate.

## Key facts

- **NCT ID:** NCT05709509
- **Lead sponsor:** RSD dr. Soebandi
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-01
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-05-01
- **Target enrollment:** 148 (ESTIMATED)
- **Last updated:** 2023-04-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05709509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05709509, "Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05709509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*